Clinical importance of serum and urine free kappa & lambda light chain concentrations in primary (AL) amyloidosis

被引：0
|
作者：
Tang, L [1 ]
Wolfenbarger, D [1 ]
Williams, T [1 ]
Weiss, D [1 ]
Solomon, A [1 ]
机构：
[1] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN 37920 USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2001年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [31] Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
    Kumar, Shaji
    Dispenzieri, Angela
    Katzmann, Jerry A.
    Larson, Dirk R.
    Colby, Colin L.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Leung, Nelson
    Zeldenrust, Steve R.
    Ramirez-Alvarado, Marina
    Clark, Raynell J.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    BLOOD, 2010, 116 (24) : 5126 - 5129
  • [32] CAN A PERSISTENTLY POSITIVE SERUM OR URINARY IMMUNOFIXATION (SIFE/UIFE), WITH NORMALIZATION OF SERUM FREE LIGHT CHAINS (FLC) ASSAY AND KAPPA/LAMBDA RATIO AFTER TREATMENT, HAVE A PROGNOSTIC IMPACT IN SYSTEMIC LIGHT CHAIN AMYLOIDOSIS (AL)?
    De Novellis, D.
    Balsamo, F.
    Pugliese, N.
    Giordano, C.
    Sierchio, L.
    Vasco, A.
    Savoia, M.
    Cerciello, G.
    Pane, F.
    HAEMATOLOGICA, 2020, 105 : S106 - S106
  • [33] B CELLS WITH BOTH SURFACE KAPPA AND LAMBDA LIGHT CHAINS ARE PRESENT IN THE CIRCULATION IN ICU PATIENTS WITH SEPSIS AND THEIR FREQUENCY CORRELATES WITH FREE LIGHT CHAIN CONCENTRATIONS IN SERUM
    Shankar-Hari, M.
    Tahir, R.
    Assi, L.
    Beale, R.
    Singer, M.
    Spencer, J.
    INTENSIVE CARE MEDICINE, 2014, 40 : S89 - S89
  • [34] Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis
    Morris, K. L.
    Tate, J. R.
    Gill, D.
    Kennedy, G.
    Wellwood, J.
    Marlton, P.
    Bird, R.
    Mills, A. K.
    Mollee, P.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (07) : 456 - 463
  • [35] The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis
    Gatt, Moshe E.
    Kaplan, Batia
    Yogev, Dean
    Slyusarevsky, Elana
    Pogrebijski, Galina
    Golderman, Sizilia
    Kukuy, Olga
    Livneh, Avi
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 86 - 92
  • [36] Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis
    Bochtler, Tilmann
    Hegenbart, Ute
    Heiss, Christiane
    Benner, Axel
    Cremer, Friedrich
    Volkmann, Martin
    Ludwig, Jochen
    Perz, Jolanta B.
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Schonland, Stefan O.
    HAEMATOLOGICA, 2008, 93 (03) : 459 - 462
  • [37] Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis
    Nguyen, Vina P.
    Rosenberg, Allison
    Mendelson, Lisa M.
    Comenzo, Raymond L.
    Varga, Cindy
    Sanchorawala, Vaishali
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2018, 25 (03): : 156 - 159
  • [38] Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis
    Shimojima, Y
    Matsuda, M
    Gono, T
    Ishii, W
    Fushumi, T
    Hoshii, Y
    Yamada, T
    Ikeda, SI
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (01): : 33 - 40
  • [39] The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
    Czyzewska, Emilia
    Wisniewska, Agnieszka
    Waszczuk-Gajda, Anna
    Ciepiela, Olga
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 13
  • [40] Differences in kappa to lambda (κ:λ) ratios of serum and urinary free light chains
    Abe, M
    Goto, T
    Kosaka, M
    Wolfenbarger, D
    Weiss, DT
    Solomon, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (02): : 457 - 462
12345